December 7, 2015
New grants and contracts from a multitude of non-profit and government organizations, as well as the private sector, help the School of Pharmacy achieve the highest funding increase among all professional and graduate schools at the University of Maryland, Baltimore.
September 17, 2015
Week-long workshop featured presentations, panel discussions, and other activities designed to broaden participants’ knowledge of comparative effectiveness research and patient-centered outcomes research.
July 16, 2015
Pharmaceutical health services researchers, in collaboration with the National Organization for Rare Disorders (NORD), will design, implement, and evaluate an educational program for NORD members
February 27, 2015
Paper from Eleanor Perfetto, PhD, reviews current PFDD activities and offers suggestions for incorporating patient input into drug development.
January 20, 2015
Dr. Eleanor Perfetto to lead new center designed to expand and improve training in comparative effectiveness research and patient-centered outcomes research.
September 9, 2014
Partnership led by the School of Pharmacy will increase the scope and impact of Alzheimer’s disease and healthy aging research.
August 29, 2014
Four teams compete for $75,000 award to fund new initiatives to advance the mission, research, and reputation of the School’s Department of Pharmaceutical Health Services Research.
April 1, 2014
Continuing education courses will prepare pharmacists and other clinical decision makers to evaluate and use comparative effectiveness research studies to make more informed health care decisions and improve patient outcomes.
March 11, 2014
Representatives from Novartis Pharmaceuticals Corporation (NPC) speak with graduate students about the excitement and challenges surrounding this emerging field of research.
February 25, 2014
Researchers from academia, government, and industry discuss how increasingly large, complex datasets can be harnessed to improve the drug development process.
July 11, 2013
Eleanor Perfetto, PhD, MS, former senior director of federal government relations at Pfizer, announced as department’s newest professor.
